1. Home
  2. NAKA vs MXCT Comparison

NAKA vs MXCT Comparison

Compare NAKA & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kindly MD Inc.

NAKA

Kindly MD Inc.

N/A

Current Price

$5.65

Market Cap

152.1M

Sector

N/A

ML Signal

N/A

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

N/A

Current Price

$1.26

Market Cap

155.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NAKA
MXCT
Founded
2019
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
152.1M
155.8M
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
NAKA
MXCT
Price
$5.65
$1.26
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
★ $13.33
$4.11
AVG Volume (30 Days)
167.1K
★ 1.6M
Earning Date
11-18-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 61.19
N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $33,026,000.00
Revenue This Year
$3,833.87
N/A
Revenue Next Year
N/A
$15.53
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$3.33
$0.64
52 Week High
$640.80
$1.81

Technical Indicators

Market Signals
Indicator
NAKA
MXCT
Relative Strength Index (RSI) 35.79 45.97
Support Level $4.38 $1.02
Resistance Level $7.59 $1.54
Average True Range (ATR) 0.62 0.15
MACD -0.16 -0.03
Stochastic Oscillator 11.82 3.12

Price Performance

Historical Comparison
NAKA
MXCT

About NAKA Kindly MD Inc.

Nakamoto Inc is a Bitcoin company building a world-wide portfolio of Bitcoin-native companies to provide commercial and financial infrastructure for the next generation of capital markets. The firm has two principal business segments: Bitcoin Operations, which houses its Bitcoin treasury and is utilized to support investments in other Bitcoin-related companies; Healthcare Operations, which provides a patient-focused healthcare experience that provides patients personalized solutions in order to reduce opioid use and improve health outcomes. The company generates the majority of its revenue from the Healthcare Operations.

About MXCT MaxCyte Inc.

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

Share on Social Networks: